Potential of non-Western medicines in chemoradiotherapy for cervical cancer

doi:10.12998/wjcc.v13.i2.100198

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

Sum=0

Jan 16, 2025 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Clin Cases. Jan 16, 2025; 13(2): 100198
Published online Jan 16, 2025. doi: 10.12998/wjcc.v13.i2.100198

Potential of non-Western medicines in chemoradiotherapy for cervical cancer

Takashi Ono, Masashi Koto

Takashi Ono, Masashi Koto, Department of Radiation Oncology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan

Author contributions: Ono T designed the overall concept and outline of the manuscript, wrote, and edited the manuscript and review of literature; Koto M supervised the manuscript; all of the authors read and approved the final version of the manuscript to be published.

Conflict-of-interest statement: The authors report no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Takashi Ono, MD, PhD, Assistant Professor, Doctor, Department of Radiation Oncology, Faculty of Medicine, Yamagata University, 2-2-2 Iida-Nishi, Yamagata 990-9585, Japan. abc1123513@gmail.com

Received: August 9, 2024
Revised: September 19, 2024
Accepted: October 8, 2024
Published online: January 16, 2025
Processing time: 90 Days and 15.6 Hours

Core Tip

Core Tip: There is currently no specific Western medical treatment for managing the toxicity associated with radiotherapy in cervical cancer, making treatment challenging. Non-Western medicines may be less toxic and more effective than Western medicines. However, further evidence is required to substantiate these benefits.